Recent News

• 03.29.2025 - Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
• 03.29.2025 - Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
• 02.04.2025 - Turnstone Biologics Announces Plans to Explore Strategic Alternatives
• 02.04.2025 - Turnstone Biologics Announces Plans to Explore Strategic Alternatives
• 11.12.2024 - Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
• 11.12.2024 - Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
• 11.05.2024 - Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
• 11.05.2024 - Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
• 10.11.2024 - Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway
• 10.11.2024 - Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway

Recent Filings

• 02.04.2025 - EX-99.1 EX-99.1
• 02.04.2025 - 8-K Current report
• 11.12.2024 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.12.2024 - 8-K Current report
• 11.12.2024 - EX-99.1 EX-99.1
• 10.11.2024 - 8-K Current report
• 10.11.2024 - EX-99.1 EX-99.1
• 10.01.2024 - 8-K Current report